Boston Scientific Corp (BSX) concluded trading on Thursday at a closing price of $90.42, with 4.05 million shares of worth about $366.27 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 17.49% during that period and on December 12, 2024 the price saw a loss of about -0.15%. Currently the company’s common shares owned by public are about 1.47B shares, out of which, 1.47B shares are available for trading.
Stock saw a price change of -0.12% in past 5 days and over the past one month there was a price change of 1.92%. Year-to-date (YTD), BSX shares are showing a performance of 56.41% which increased to 61.61% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $54.95 but also hit the highest price of $91.93 during that period. The average intraday trading volume for Boston Scientific Corp shares is 5.81 million. The stock is currently trading 0.46% above its 20-day simple moving average (SMA20), while that difference is up 3.06% for SMA50 and it goes to 15.74% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Boston Scientific Corp (NYSE: BSX) currently have 1.47B outstanding shares and institutions hold larger chunk of about 91.34% of that.
The stock has a current market capitalization of $133.26B and its 3Y-monthly beta is at 0.80. PE ratio of stock for trailing 12 months is 74.79, while it has posted earnings per share of $1.21 in the same period. Its PEG reads 5.27 and has Quick Ratio of 1.02 while making debt-to-equity ratio of 0.54. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BSX, volatility over the week remained 1.48% while standing at 1.67% over the month.
Stock’s fiscal year EPS is expected to rise by 20.05% while it is estimated to increase by 13.54% in next year. EPS is likely to grow at an annualized rate of 14.20% for next 5-years, compared to annual growth of -2.05% made by the stock over the past 5-years.
Coverage by Goldman stated Boston Scientific Corp (BSX) stock as a Buy in their note to investors on May 30, 2024, suggesting a price target of $90 for the stock. On February 01, 2024, Mizuho Upgrade their recommendations, while on July 19, 2023, Robert W. Baird Initiated their ratings for the stock with a price target of $59. Stock get a Buy rating from CL King on June 30, 2023.
